Self-management for Youth With Epilepsy Pilot
SMART-Y pilot
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
Pilot feasibility and acceptability trial of the SMART-Y intervention in a small group of adolescents (n=18), age 14-17
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2026
CompletedFirst Posted
Study publicly available on registry
October 15, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
October 1, 2027
October 15, 2026
October 1, 2026
10 months
October 8, 2026
October 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility 1 - Session Attendance Rate
Percentage of scheduled intervention sessions attended during the 12-week intervention period. Each participant will be scheduled to attend 8 weekly intervention sessions; therefore, the total number of scheduled sessions will be calculated as the number of participants enrolled multiplied by 8 sessions.
8 weeks
Feasibility 2 - Intervention Sessions Retention
Proportion of participants who attended 75% of the sessions. Retention to sessions will be calculated as the number of participants attending at least 6 of the 8 scheduled intervention sessions divided by the total number of participants enrolled.
8 weeks
Feasibility 3 - Assessment Retention
Percentage of participants who complete both the baseline and 12-week assessments. Assessment retention will be calculated as the number of participants completing both assessments divided by the number of participants enrolled.
12 weeks
Secondary Outcomes (4)
Change in 30-Day Seizure Count
Baseline, 12 weeks
Change in Negative Health Events (NHE) Total Score
Baseline, 12 weeks
Change in PedsQL Epilepsy Module Standard Version Total Score
Baseline, 12 weeks
Change in PedsQL Epilepsy Module Acute Version Total Score
Baseline, 12 weeks
Study Arms (1)
Experimental: [SMART-Y]
EXPERIMENTALInterventions
SMART-Y is a youth-focused adaptation of SMART ( Self-MAnagement for people with epilepsy and a histoRy of negative health evenTs) developed for adolescents transitioning into adulthood. SMART is a remotely delivered, real-time group intervention that supports epilepsy self-management among individuals with recent epilepsy-related complications. The program emphasizes seizure control, lifestyle management, and emotional health.
Eligibility Criteria
You may qualify if:
- Age 14-17
- Diagnosed with epilepsy, per clinician or chart diagnosis
- Has parent/guardian that is able/willing to consent (parent does not have to also participate, just has to consent to the youth's participation)
- Speaks English
You may not qualify if:
- Comorbid Dx: moderate-severe intellectual disability
- Unable to assent to the study
- Unable to meaningfully participate in the intervention sessions or assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Sajatovic M, Tatsuoka C, Welter E, Perzynski AT, Colon-Zimmermann K, Van Doren JR, Bukach A, Lawless ME, Ryan ER, Sturniolo K, Lhatoo S. Targeted Self-Management of Epilepsy and Mental Illness for individuals with epilepsy and psychiatric comorbidity. Epilepsy Behav. 2016 Nov;64(Pt A):152-159. doi: 10.1016/j.yebeh.2016.08.012. Epub 2016 Oct 12.
PMID: 27743547BACKGROUNDSajatovic M, Jobst BC, Shegog R, Bamps YA, Begley CE, Fraser RT, Johnson EK, Pandey DK, Quarells RC, Scal P, Spruill TM, Thompson NJ, Kobau R. The Managing Epilepsy Well Network:: Advancing Epilepsy Self-Management. Am J Prev Med. 2017 Mar;52(3 Suppl 3):S241-S245. doi: 10.1016/j.amepre.2016.07.026.
PMID: 28215372BACKGROUNDSajatovic M, Colon-Zimmermann K, Kahriman M, Fuentes-Casiano E, Liu H, Tatsuoka C, Cassidy KA, Lhatoo S, Einstadter D, Chen P. A 6-month prospective randomized controlled trial of remotely delivered group format epilepsy self-management versus waitlist control for high-risk people with epilepsy. Epilepsia. 2018 Sep;59(9):1684-1695. doi: 10.1111/epi.14527. Epub 2018 Aug 10.
PMID: 30098003BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Molly K McVoy, MD
University Hospitals Cleveland Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician
Study Record Dates
First Submitted
October 8, 2026
First Posted
October 15, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
October 15, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
This is an internal pilot study.